Disclosures for "Efficacy and Safety of Erenumab for Chronic Migraine and Medication Overuse: A Comprehensive Systematic Review and Single Arm Meta-Analysis"
-
Miss Silva has nothing to disclose.
-
Mr. De Sousa Marinho Mendes Filho has nothing to disclose.
-
Mr. Abraham has nothing to disclose.
-
Mr. Pedrosa has nothing to disclose.
-
Miss Salema Pascual has nothing to disclose.
-
Dr. Dominici has nothing to disclose.
-
Miss Weba has nothing to disclose.
-
Mr. Fukunaga has nothing to disclose.
-
Miss Nascimento has nothing to disclose.
-
Dr. De Siqueira Lima has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. De Siqueira Lima has stock in Moderna. Dr. De Siqueira Lima has stock in Johnson & Johnson. Dr. De Siqueira Lima has stock in Pfizer.